Biomarker Summit 2013
|
Register by August 9th, 2013 for a 20% Discount. Or
register 2 and the 3rd goes
FREE with the coupon code
RCDVB! |
|
Dear Colleague,
GTC would like to invite you to attend our Biomarker Europe Summit 2013
on October 9th-10th in Berlin, Germany. The summit will address
the latest developments in the biomarker arena from discovery to translation to
commercialization. Presentations span across multiple disciplines and cover
topics such as discovery and validation strategies, the challenges of clinical
translation, novel technologies including next-generation sequencing, regulatory
and reimbursement issues and companion diagnostics. Scientific data, case
studies and discussions will be facilitated by key representatives from pharma,
biotech, academia and the public sector.
The summit will consist of two co-located conferences that will focus on
different stages of biomarker development. Below is an outline with the
sessions for the two conferences:
|
|
MEDIA PARTNERS |
|
 |
|
 |
|
|
|
Biomarkers in Drug
Discovery & Development |
- Biomarker Discovery
& Identification Strategies
- Biomarkers to
Validate Potential Drug Targets
- Safety, Efficacy
and PK/PD Biomarkers in Drug Development
- Biomarkers as
Surrogate Endpoints
- Applications of
Imaging Biomarkers & Tracers
- The Statistics Methods Underlying Successful
Biomarker Discovery and Validation
- Overcoming
Challenges of Clinical Translation – Case Studies
|
|
Biomarkers in
Diagnostics |
- New Diagnostic
Biomarkers & Their Development
- Novel Diagnostic
Technologies
- Predictive VS
Prognostic Biomarkers in Personalized Medicine
- Biomarkers for Personalized Prevention Strategies
- Next Generation
Sequencing in the Clinic
- Companion
Diagnostics Development & Partnering
- Prospects of Systems Medicine in Personalized
Medicine
|
|
General Session (both
tracks)
|
- Regulatory
Landscape and Trends for Biomarker Assays
- Health Economics
Value of Biomarker and Reimbursement Environment
|
This summit is part of the
Drug Discovery Week Europe 2013 on October 7th-10th and will
follow the
Next Generation
Sequencing & Bioinformatics Summit (Oct. 7-8)
Members of the Advisory Board:
Daniel Chelsky, Chief Scientific Officer, Caprion Proteome
Ulrich Hoffmueller, Chief Business Officer and Founder, Epiontis
Michael Koslowski, Director, Head, Translational Medicine Experts,
Boehringer-Ingelheim
Brian Leyland-Jones, Director, Edith Sanford Breast Cancer Institute, Sanford
Health
Pierluigi Mauri, Chief of Proteomics and Metabolomics Lab, Institute for
Biomedical Technologies (ITB-CNR)
Suso Platero, Director, Oncology Biomarkers, Janssen Pharmaceuticals
Achim Plum, Principle Consultant, Corporate Technology, Siemens AG
Gabriela Suchanko, Senior Personalized Healthcare Leader, F.Hoffmann-La Roche
Laszlo Takacs, Chief Scientific Officer, BioSystems International SAS
E.G. Elisabeth de Vries, Professor of Medical Oncology, University Medical
Center Groningen
Call for Papers!
To be considered for an oral presentation, please submit an abstract
here by
September 9th, 2013. Selected presentations will be based on quality of abstract
and availability. Presentation slots fill up fast so please submit your abstract
ASAP.
Sponsorship and exhibiting opportunities are available in a range of levels,
which can be tailored to fit your needs. Please contact 626-256-6405 x102 or
spex@gtcbio.com
for more information.
Best Regards,
Organizing
Committee
See you in Berlin!
|
 |
Attend ALL GTC Conferences for One Year
for only $3995 ($1990 for acad/govt)
Click
here to sign up! |
|
|
